Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ascent Bio-Nano Technologies
AddedFeb 16, 2024
UpdatedJun 18, 2026
Ascent Bio-Nano Technologies

Ascent Bio-Nano Technologies

Ascent Bio-Nano: NC-based manufacturer developing affordable mini flow cytometry instruments.

HQ
Morrisville, NC, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Founded in Morrisville, North Carolina, Ascent Bio-Nano Technologies is dedicated to developing affordable, miniature flow cytometry instruments. Leveraging patented technologies from Penn State University, the company aims to revolutionize the biomedical field by making advanced diagnostic tools more accessible and cost-effective. Their core mission is to enhance healthcare through innovative, compact, and user-friendly devices that can be widely deployed in various medical settings.

Notable affiliations include partnerships with Penn State University, which provided the foundational technologies for their products. The company has achieved significant milestones in miniaturizing flow cytometry instruments, making them more affordable without compromising on performance. Ascent Bio-Nano's impact lies in democratizing access to advanced diagnostic tools, potentially transforming how diseases are diagnosed and monitored globally.

Ascent Bio-Nano Technologies - Similar Companies

BioNanovations logo

BioNanovations

LeukoDx logo

LeukoDx

Nanotools Bioscience logo

Nanotools Bioscience

nanotoolsbio.com

NanoCytomics logo

NanoCytomics

nano-cytomics.com

NanoDx logo

NanoDx

Nanoscope Technologies logo

Nanoscope Technologies

Nanostream logo

Nanostream

nanostream.com

Nano Mobile Healthcare logo

Nano Mobile Healthcare

3i Nanotech logo

3i Nanotech

Nanovis logo

Nanovis

Nanobiofab logo

Nanobiofab

nanobiofab.com

Bioforce Nanosciences Holdings logo

Bioforce Nanosciences Holdings

bioforcenano.com

BennuBio logo

BennuBio

bennubio.com

Akron Ascent Innovations logo

Akron Ascent Innovations

NanoMosaic logo

NanoMosaic

Ascent Bio-Nano Technologies - Quick Facts

Who are Ascent Bio-Nano Technologies' competitors?

Companies similar to Ascent Bio-Nano Technologies include BioNanovations, LeukoDx, Nanotools Bioscience and NanoCytomics.

When was Ascent Bio-Nano Technologies founded?

Ascent Bio-Nano Technologies was founded in 2012.

Where is Ascent Bio-Nano Technologies' headquarters located?

Ascent Bio-Nano Technologies' headquarters is located in Morrisville, NC, US.

When was Ascent Bio-Nano Technologies' last funding round?

Ascent Bio-Nano Technologies' most recent funding round was for $900k (USD) in August 2015.

How much has Ascent Bio-Nano Technologies raised to-date?

As of Aug 28, 2015, Ascent Bio-Nano Technologies has raised a total of $1.2M (USD).

How many employees does Ascent Bio-Nano Technologies have?

Ascent Bio-Nano Technologies has 2 employees as of Feb 4, 2024.

Ascent Bio-Nano Technologies - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Main Product
  • Medical Devices
Tags
  • Biotech
NAICS
  • 330000Manufacturing
SIC
  • 3900Miscellaneous Manufacturing Industries